Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2003-05-26 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MONTCUQ-EN-QUERCY-BLANC (46800), Lot
PHARMACIE NEAU : revenue, balance sheet and financial ratios
PHARMACIE NEAU is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MONTCUQ-EN-QUERCY-BLANC (46800),
this company of category PME
shows in 2023 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE NEAU (SIREN 448707356)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
2 931 806 €
2 776 283 €
2 273 604 €
2 183 673 €
2 123 584 €
Net income
-13 998 €
3 182 €
110 718 €
224 506 €
682 311 €
94 671 €
103 129 €
EBITDA
N/C
N/C
169 955 €
330 746 €
221 682 €
156 101 €
159 231 €
Net margin
N/C
N/C
3.8%
8.1%
30.0%
4.3%
4.9%
Revenue and income statement
In 2025, PHARMACIE NEAU records a net loss of 14 k€. This deficit will reduce equity on the balance sheet.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-13 998 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 90%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
0.814%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
90.382%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
35.451
26.054
13.37
7.779
3.682
2.183
0.814
Financial autonomy
64.987
70.654
79.211
84.013
86.447
87.503
90.382
Repayment capacity
3.779
3.149
1.852
0.744
0.677
None
None
Cash flow / Revenue
6.35%
5.804%
7.028%
9.187%
4.73%
None%
None%
Sector positioning
Debt ratio
0.812025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Excellent
In 2025, the debt ratio of PHARMACIE NEAU (0.81) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
90.38%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Excellent+14 pts over 3 years
In 2025, the financial autonomy of PHARMACIE NEAU (90.4%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.68 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE NEAU (0.68) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 441.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
441.677
Liquidity indicators evolution PHARMACIE NEAU
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
157.635
155.433
173.411
219.222
209.862
392.125
441.677
Interest coverage
3.4
2.907
1.683
0.875
1.207
None
None
Sector positioning
Liquidity ratio
441.682025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Excellent+19 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE NEAU (441.68) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.21x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE NEAU (1.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE NEAU
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Operating WCR
208 897 €
192 665 €
170 930 €
148 281 €
221 908 €
0 €
0 €
Inventory turnover (days)
27
30
28
23
24
0
0
Customer payment term (days)
10
7
12
6
6
0
0
Supplier payment term (days)
47
39
35
30
33
0
0
Positioning of PHARMACIE NEAU in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE NEAU with other companies in the same sector:
The headquarters of PHARMACIE NEAU is located in MONTCUQ-EN-QUERCY-BLANC (46800), in the department Lot.
Where to find the tax return of PHARMACIE NEAU ?
The tax return of PHARMACIE NEAU is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE NEAU operate?
PHARMACIE NEAU operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart